昨日(8月12日),国家医保局公布《关于公示通过2025年国家基本医疗保险、生育保险和工伤保险药品目录及商保创新药目录调整初步形式审查的药品及相关信息的公告》。其中,初次亮相的商保目录成关注焦点。根据公告,共有141款创新药申报了商保目录,其中121款成功通过初审,淘汰率约为14%。多款“明星药物”在列,如国内已获批上市的5款CAR-T疗法、辉瑞旗下国内首个获批用于治疗白血病的ADC奥加伊妥珠单抗...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.